Antidiabetics Market Analysis

 Product (Insulin, Drug Class)

Insulin segment is predicted to capture antidiabetics market share of over 53.5% by 2037, owing to its effective results in diabetic care. Insulin is one of the most preferred therapies for diabetes control and offers effective results in type 1 patients.  According to the National Institute of Diabetes and Digestive and Kidney Diseases, type 1 diabetic patients are suggested to take insulin as their bodies do not make it.  The ways to take insulin are through insulin pens, insulin pumps, and syringes, automated insulin delivery system or artificial pancreas is also an option to take insulin for some patients.

Patient Population (Pediatric, Adults, Geriatric)

The geriatric segment in antidiabetics market is expected to hold a dominant revenue share through the forecasted period. Senior people are more prone to chronic disorders such as diabetes and often require antidiabetics such as insulin to control and maintain their glucose levels. Obesity, lack of proper diet, and a sedentary lifestyle are prevalent among the older population, which contributes to a high risk of diabetes leading to growing sales of antidiabetics. For instance, according to the Endocrine Society report, 33% of diabetic patients are aged 65 or older, and have a high risk of developing diabetes-related issues such as kidney failure, heart disorder, and hypoglycemia.

Our in-depth analysis of the antidiabetics market includes the following segments: